• Publications
  • Influence
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen‐deficient rats
The data indicate that the divalent strontium salt S12911 is acting as an uncoupling agent that can prevent the femoral osteopenia and partially prevent the trabecular bone loss in E2‐deficient rats by inhibiting bone resorption without reducing bone formation.
Tools in the Assessment of Sarcopenia
It is proposed that sarcopenia may be optimally defined using a combination of measures of muscle mass and physical performance and co-primary outcomes, tailored to the specific intervention in question, may be the best way forward in this difficult but clinically important area.
Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration
The analysis of the interaction of strontium (Sr) with bone mineral is of interest because a new agent containing Sr (S 12911) has shown positive effects on bone mass in various animal models of
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper
There is currently no evidence that osteoporosis treatments are detrimental for bone repair and some promising experimental evidence for positive effects on healing, notably for agents with a bone-forming mode of action, which may translate into therapeutic applications.
Frailty and sarcopenia: definitions and outcome parameters
Evidence is required for a link between improvements in the measures of muscle strength and/or physical activity and clinical outcomes to allow development of interventions to improve clinical outcomes in frail older patients.
Strontium Ranelate Increases Cartilage Matrix Formation
Strontium ranelate strongly stimulates human cartilage matrix formation in vitro by a direct ionic effect without stimulating the chondroresorption processes, providing a preclinical basis for in vivo testing of strontium runelate in OA.